快播成人网

Ellen Fraint, MD

Hematology/Oncology

Primary Office

快播成人网 Children's Hospital, Delaware 快播成人网 Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

What I'm Passionate About

I鈥檓 passionate about providing compassionate, individualized, patient-centered care for children with cancer, blood and immune disorders, and other life-threatening conditions. I also care deeply about advocating for the health of our communities, including making sure that local and federal policies maximize the ability for children to access these complex life-changing therapies.聽

Education & Training

Fellowship

  • Pediatric Hematology/Oncology - Albert Einstein College of Medicine Program, 2020
  • Ped. Bone Marrow Transplant - Memorial Sloan Kettering Cancer Center, 2021

Residency

  • General Pediatrics - Thomas Jefferson Univ / A.I.duPont Hosp Children, 2017

Medical/Dental School

  • M.D. - University of Pennsylvania School of Medicine, 2014

Board Certifications

  • American Board of Pediatrics/General Pediatrics
  • American Board of Pediatrics/Pediatric Hematology-Oncology

Insurance Accepted

  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna PPO/EPO/POS
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
  • Amerihealth Caritas Delaware
  • Amerihealth Caritas Delaware Next
  • Cigna & Great West HMO/POS/EPO
  • Cigna & Great West PPO
  • Cigna Lifesource Transplant
  • Cigna/Great West HMO EPO POS
  • Delaware First Health
  • Delaware Medicaid/Diamond State
  • Delaware Medicare
  • Devon Health Services
  • Fidelis Care NJ Medicaid HMO
  • First Health PPO
  • First Health/Affordable PPO
  • Geisinger Health Plan Commercial
  • Global Medical Managment DE/PA
  • Global Medical Mangment NJ
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Blue Cross Blue Shield of Delaware *PA Loc Contiguous to DE*
  • Highmark Blue Cross Blue Shield of Delaware *PA Loc NONContiguous to DE*
  • Highmark Blue Cross Blue Shield of Pennsylvania
  • Highmark Medicaid Health Options
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Interlink Transplant
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Multiplan PPO
  • National Transplant (Humana)
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO DE/PA
  • Olympus Managed Healthcare PPO NJ
  • Pennsylvania Medicaid
  • Preferred Healthcare PPO
  • Priority Partners John Hopkins
  • Private Health Care Systems (PHCS)
  • Private Healthcare Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Star Healthcare Network
  • Star Healthcare Network
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services/CHAMPVA
  • United Healthcare of the Mid-Atlantic
  • UPMC MCAID/CHIP PA DE
  • US Family Health Plan
  • Wellpoint Maryland Medcaid

  • Blood Disorders
  • Cancer Care
  • Leukemia
  • Lymphoma
  • Sickle Cell Disease
  • Solid Tumors

  • Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy; Journal of Pediatric Hematology/Oncology; (2023).

  • Hematopoietic Stem and Progenitor Cell Identification and Transplantation in Zebrafish; Methods in Molecular Biology; (2023).

  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma; Leukemia; (2023).

  • No impact of CD34<sup>+</sup> cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma; Bone Marrow Transplantation; (2023).

  • Mediport use as an acceptable standard for CAR T cell infusion; Frontiers in Immunology; (2023).

  • Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation; Transplantation and Cellular Therapy; (2023).

  • Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines; Transplantation and Cellular Therapy; (2023).

  • Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors; Transplantation and Cellular Therapy; (2023).

  • Successful Bone Marrow Transplantation with Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants; Journal of Pediatric Hematology/Oncology; (2022).

  • Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma; Transplantation and Cellular Therapy; (2022).

  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy; Transplantation and Cellular Therapy; (2021).

  • Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation; Stem Cells Translational Medicine; (2021).

  • Pediatric hematopoietic stem cell transplant; Pediatrics in Review; (2020).

  • A novel conditioning-free hematopoietic stem cell transplantation model in zebrafish; Blood Advances; (2020).

  • The splicing factor Sf3b1 regulates erythroid maturation and proliferation via TGFb signaling in zebrafish; Blood Advances; (2019).

  • Progress toward liquid biopsies in pediatric solid tumors; Cancer and Metastasis Reviews; (2019).

  • Posterior reversible encephalopathy syndrome and cerebral sinus thrombosis in a case of pediatric B-Cell ALL; Journal of Pediatric Hematology/Oncology; (2017).

  • Coexisting Juvenile Dermatomyositis and Sickle Cell Disease: Maintaining a High Degree of Suspicion; Journal of Pediatrics; (2017).

  • English